基本信息
浏览量:227
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
The aims of Dr. Oxnard’s research are to develop clinical applications for cancer genotyping technologies to advance precision cancer care.
Dr. Oxnard has published extensively on sensitivity and resistance to EGFR kinase inhibitors in lung cancer with a focus on the clinical biology of the EGFR T790M mutation. More recently his research has focused on genomic analysis of plasma cell-free DNA as a diagnostic to assist in treatment planning, response monitoring, and cancer detection.
Dr. Oxnard has published extensively on sensitivity and resistance to EGFR kinase inhibitors in lung cancer with a focus on the clinical biology of the EGFR T790M mutation. More recently his research has focused on genomic analysis of plasma cell-free DNA as a diagnostic to assist in treatment planning, response monitoring, and cancer detection.
研究兴趣
论文共 548 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
B. Miron, G. Li, J.C.F. Quintanilha, A. Clark, T. Scott, J.S. Ross,G.R. Oxnard, L.W. Pasquina,R.P. Graf,S. Gupta
ESMO Real World Data and Digital Oncology (2024): 100004-S1220
JOURNAL OF THORACIC ONCOLOGYno. 2 (2024): 227-239
crossref(2024)
Alessandro Russo,Jessica K Lee,Lincoln W Pasquina,Marzia Del Re, Holli H Dilks,Karthikeyan Murugesan,Russell W Madison,Yi Lee,Alexa B Schrock, Leah Comment, Martin Dietrich,Geoffrey R Oxnard,
JCO precision oncology (2024): e2300535-e2300535
Miles C Andrews,Gerald Li,Ryon P Graf,Virginia A Fisher, Jerry Mitchell, Ali Aboosaiedi, Harriet O'Rourke,Mark Shackleton,Mahesh Iddawela,Geoffrey R Oxnard,Richard S P Huang
JCO precision oncology (2024): e2300640-e2300640
crossref(2024)
LUNG CANCER (2024): 107454-107454
Cancer Researchno. 6_Supplement (2024): 971-971
crossref(2024)
crossref(2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn